AAAAAA
Results:
1-23
|
Results: 23
Authors:
Franco, RF
Fagundes, MG
Meijers, JCM
Reitsma, PH
Lourenco, D
Morelli, V
Maffei, FH
Ferrari, IC
Piccinato, CE
Silva, WA
Zago, MA
Citation: Rf. Franco et al., Identification of polymorphisms in the 5 '-untranslated region of the TAFIgene: relationship with plasma TAFI levels and risk of venous thrombosis, HAEMATOLOG, 86(5), 2001, pp. 510-517
Authors:
Franco, RF
Reitsma, PH
Citation: Rf. Franco et Ph. Reitsma, Genetic risk factors of venous thrombosis, HUM GENET, 109(4), 2001, pp. 369-384
Authors:
ten Cate, H
Schoenmakers, SHHF
Franco, R
Timmerman, JJ
Groot, AP
Spek, A
Reitsma, PH
Citation: H. Ten Cate et al., Microvascular coagulopathy and disseminated intravascular coagulation, CRIT CARE M, 29(7), 2001, pp. S95-S97
Authors:
van der Vliet, HN
Sammels, MG
Leegwater, ACJ
Levels, JHM
Reitsma, PH
Boers, W
Chamuleau, RAFM
Citation: Hn. Van Der Vliet et al., Apolipoprotein A-V - A novel apolipoprotein associated with an early phaseof liver regeneration, J BIOL CHEM, 276(48), 2001, pp. 44512-44520
Authors:
Spek, CA
Reitsma, PH
Citation: Ca. Spek et Ph. Reitsma, Genetic risk factors for venous thrombosis, MOL GEN MET, 71(1-2), 2000, pp. 51-61
Authors:
Stokkers, PCF
Huibregtse, K
Leegwater, AC
Reitsma, PH
Tytgat, GNJ
van Deventer, SJH
Citation: Pcf. Stokkers et al., Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2, INFLAMM B D, 6(2), 2000, pp. 92-98
Authors:
van Aken, BE
Jansen, J
van Deventer, SJH
Reitsma, PH
Citation: Be. Van Aken et al., Elevated levels of homocysteine increase IL-6 production in monocytic MonoMac 6 cells, BL COAG FIB, 11(2), 2000, pp. 159-164
Authors:
Gandrille, S
Borgel, D
Sala, N
Espinosa-Parrilla, Y
Simmonds, R
Rezende, S
Lind, B
Mannhalter, C
Pabinger, I
Reitsma, PH
Formstone, C
Cooper, DN
Saito, H
Suzuki, K
Bernardi, F
Aiach, M
Citation: S. Gandrille et al., Protein S deficiency: A database of mutations - Summary of the first update, THROMB HAEM, 84(5), 2000, pp. 918-918
Authors:
van Aken, BE
den Heijer, M
Bos, GMJ
van Deventer, SJH
Reitsma, PH
Citation: Be. Van Aken et al., Recurrent venous thrombosis and markers of inflammation, THROMB HAEM, 83(4), 2000, pp. 536-539
Authors:
Kraaijenhagen, RA
Anker, PSI
Koopman, MMW
Reitsma, PH
Prins, MH
van den Ende, A
Buller, HR
Citation: Ra. Kraaijenhagen et al., High plasma concentration of factor ville is a major risk factor for venous thromboembolism, THROMB HAEM, 83(1), 2000, pp. 5-9
Authors:
Reitsma, PH
Citation: Ph. Reitsma, Genetic heterogeneity in hereditary thrombophilia, HAEMOSTASIS, 30, 2000, pp. 1-10
Authors:
Franco, RF
Middeldorp, S
Meinardi, JR
van Pampus, ECM
Reitsma, PH
Citation: Rf. Franco et al., Factor XIII Va134Leu and the risk of venous thromboembolism in factor V Leiden carriers, BR J HAEM, 111(1), 2000, pp. 118-121
Authors:
Franco, RF
de Jonge, E
Dekkers, PEP
Timmerman, JJ
Spek, CA
van Deventer, SJH
van Deursen, P
van Kerkhoff, L
van Gemen, B
ten Cate, H
van der Poll, T
Reitsma, PH
Citation: Rf. Franco et al., The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation, BLOOD, 96(2), 2000, pp. 554-559
Authors:
ten Hove, T
Vervoordeldonk, MJBM
Dekkers, PEP
Reitsma, PH
van Deventer, SJH
Citation: T. Ten Hove et al., LPS induced translocation of NF-kappa B occurs only in a subpopulation of CD14-positive mononuclear cells, J ENDOTOX R, 5(1-2), 1999, pp. 15-21
Authors:
Doggen, CJM
Bertina, RM
Cats, VM
Reitsma, PH
Rosendaal, FR
Citation: Cjm. Doggen et al., The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction, THROMB HAEM, 82(1), 1999, pp. 115-120
Authors:
Franco, RF
Reitsma, PH
Lourenco, D
Maffei, FH
Morelli, V
Tavella, MH
Araujo, AG
Piccinato, CE
Zago, MA
Citation: Rf. Franco et al., Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis, THROMB HAEM, 81(5), 1999, pp. 676-679
Authors:
Spek, CA
Bertina, RM
Reitsma, PH
Citation: Ca. Spek et al., Unique distance- and DNA-turn-dependent interactions in the human protein C gene promoter confer submaximal transcriptional activity, BIOCHEM J, 340, 1999, pp. 513-518
Authors:
Stokkers, PCF
de Heer, K
Leegwater, AC
Reitsma, PH
Tytgat, GNJ
van Deventer, SJH
Citation: Pcf. Stokkers et al., Inflammatory bowel disease and the genes for the natural resistance-associated macrophage protein-1 and the interferon-gamma receptor 1, INT J COL R, 14(1), 1999, pp. 13-17
Authors:
Stokkers, PCF
Reitsma, PH
Tytgat, GNJ
van Deventer, SJH
Citation: Pcf. Stokkers et al., HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis, GUT, 45(3), 1999, pp. 395-401
Authors:
Franco, RF
Trip, MD
ten Cate, H
van den Ende, A
Prins, MH
Kastelein, JJP
Reitsma, PH
Citation: Rf. Franco et al., The 20210 G -> A mutation in the 3 '-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease, BR J HAEM, 104(1), 1999, pp. 50-54
Authors:
Boers, W
Linthorst, C
Reitsma, PH
Citation: W. Boers et al., Identification of expressed genes from transformed human stellate cells associated with liver fibrosis., CELLS OF THE HEPATIC SINUSOID, VOL 7, 1999, pp. 171-172
Authors:
Spek, CA
Bertina, RM
Reitsma, PH
Citation: Ca. Spek et al., Identification of evolutionarily invariant sequences in the protein C genepromoter, J MOL EVOL, 47(6), 1998, pp. 663-669
Authors:
Verhoeff, BJ
Trip, MD
Prins, MH
Kastelein, JJP
Reitsma, PH
Citation: Bj. Verhoeff et al., The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis, ATHEROSCLER, 141(1), 1998, pp. 161-166
Risultati:
1-23
|